NCT04857515

Clinical Learning Study for a Mobile Smoking Cessation Program

An Exploratory, Observational, Open-label, Remote Study of Clickotine: A Digital Therapeutic

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 78 (actual)
• Sponsor: Click Therapeutics, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study are to obtain learnings regarding the Digital Therapeutic (DTx) experience of Clickotine, including acceptability and preference of the overall program and specific DTx components, as well as to obtain learnings related to adult participants' use of the DTx for smoking cessation.

Conditions

• Smoking Cessation
• Smoking Behaviors
• Smoking Reduction
• Smoking, Cigarette
• Smoking
• Nicotine Dependence

Interventions

Type	Name	Description
DEVICE	Clickotine®	Clickotine is a DTx that contains behavior modification techniques that include controlled breathing, social engagement, personalized messaging, medication access and adherence, digital diversions, and financial incentives.

Timeline

• Start date: 2021-03-12
• Primary completion: 2021-06-28
• Completion: 2021-06-28
• First posted: 2021-04-23
• Last updated: 2021-08-17

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study